+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cisatracurium Besilate Injection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129624
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cisatracurium Besilate Injection market is evolving quickly as healthcare providers seek greater precision, reliability, and supply resilience in anesthesia protocols. This emerging landscape is shaped by new monitoring technologies, dynamic regulatory pressure, and ongoing supply chain realignment, making strategic market insights critical for senior decision-makers.

Market Snapshot: Cisatracurium Besilate Injection Market

The global Cisatracurium Besilate Injection market demonstrates consistent growth, driven by robust adoption across major healthcare systems and diverse surgical applications. As hospitals and outpatient centers prioritize safe, organ-independent muscle relaxation solutions, market expansion is bolstered by increasing investments in monitoring technologies, improved access in emerging economies, and adaptive supply chain strategies. Key industry players continue to leverage innovation and partnerships to maintain relevance and competitive positioning in a shifting regulatory environment.

Scope & Segmentation

This report offers granular segmentation and analysis to support data-driven decisions across the value chain. The following categories define the structure and range of the Cisatracurium Besilate Injection market:

  • End User: Ambulatory Surgical Centers, including both multi-specialty and single-specialty facilities; Hospitals, spanning private and public institutions; Specialty Clinics such as dental and ophthalmic clinics.
  • Distribution Channel: Hospital Pharmacies (corporate and private), Online Pharmacies (branded and independent e-pharmacies), and Retail Pharmacies (chain and independent).
  • Form: Powder for reconstitution and premixed solution presentations shape selection criteria by case volume and operational efficiency.
  • Strength: Available in 2 Mg/Ml and 5 Mg/Ml variants to accommodate patient and procedure requirements.
  • Route: Administered via intramuscular injection, intravenous bolus, or intravenous infusion based on clinical urgency and practice standards.
  • Application: Utilized in cardiovascular (e.g., coronary artery bypass, heart valve surgery), general (laparoscopic, open surgery), neurological (craniotomy, spinal surgery), obstetrics & gynecology (cesarean section, hysterectomy), and orthopedic surgeries (arthroscopy, joint replacement).
  • Regions: Coverage spans the Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including UK, Germany, France, South Africa, Turkey, Israel, and others); Asia-Pacific (China, India, Japan, Australia, Singapore, and more).
  • Leading Companies: Pfizer Inc., Fresenius Kabi AG, Sandoz International GmbH, Teva Pharmaceutical Industries Limited, Hikma Pharmaceuticals PLC, Viatris Inc., Baxter International Inc., Sun Pharmaceutical Industries Limited, Zhejiang Hisun Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Cisatracurium besilate’s organ-independent elimination pathway enables reliable dosing in patients with hepatic or renal impairment, supporting clinical confidence during high-complexity interventions.
  • The minimal histamine release and hemodynamic stability of this agent translate to enhanced safety and tighter intraoperative control, especially for lengthy or intricate procedures.
  • Real-time integration with quantitative neuromuscular monitoring and closed-loop management platforms enhances dosing precision and minimizes residual blockade risk.
  • Market growth is reinforced by the proliferation of ambulatory and specialty surgical centers that value rapid, predictable recovery profiles and tailored dosing regimens.
  • Strategic alliances among global and regional market players have intensified, with expansion into new applications, such as pediatric surgery, broadening the agent’s clinical reach.

Tariff Impact and Supply Chain Adjustments

Implementation of United States tariffs in 2025 on active pharmaceutical ingredients has prompted manufacturers to diversify sourcing and regionalize production to mitigate import risks. Manufacturers are investing in internal process improvements and forging new third-party alliances to ensure compliance and continuity, reinforcing overall market resilience.

Research Methodology & Data Sources

Our analysis combines systematic reviews of recognized clinical and industry literature, in-depth interviews with anesthesia professionals and procurement leaders, and examination of regulatory filings. Multi-stage qualitative and quantitative validation minimizes bias and supports the reliability of findings.

Why This Report Matters for Strategic Planning

  • Identifies evolving market priorities and technology enablers for procurement, commercial, and clinical teams to make informed capital allocation and supply decisions.
  • Equips stakeholders with actionable intelligence to secure competitive positions and adapt to ongoing regulatory, technological, and tariff-driven changes.
  • Supports the development of regionally tailored commercialization strategies by outlining distinct adoption drivers and procurement dynamics country by country.

Conclusion

Cisatracurium Besilate Injection continues to play a pivotal role in modern anesthesia, backed by strong market fundamentals and adaptive business strategies. Stakeholders equipped with focused analysis will be positioned for operational excellence and sustained growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of cisatracurium besilate infusion protocols in intensive care units for prolonged neuromuscular blockade management
5.2. Impact of emerging biosimilar formulations on the pricing dynamics and accessibility of cisatracurium besilate injection
5.3. Trends in anesthesia practice with preference shift toward cisatracurium besilate for elderly and renal impairment patients
5.4. Expansion of hospital formularies and procurement strategies influenced by bundled purchasing agreements for cisatracurium besilate injection
5.5. Research insights into reduced histamine release profiles driving increased usage of cisatracurium besilate in critical care settings
5.6. Regulatory approvals of generic cisatracurium besilate products boosting competition and driving down treatment costs
5.7. Advances in drug delivery systems and prefilled syringe formats improving dosing accuracy of cisatracurium besilate injection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cisatracurium Besilate Injection Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.2.1. Multi-Specialty Centers
8.2.2. Single-Specialty Centers
8.3. Hospitals
8.3.1. Private Hospitals
8.3.2. Public Hospitals
8.4. Specialty Clinics
8.4.1. Dental Clinics
8.4.2. Ophthalmic Clinics
9. Cisatracurium Besilate Injection Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Corporate Hospital Pharmacies
9.2.2. Private Hospital Pharmacies
9.3. Online Pharmacy
9.3.1. Branded E-Pharmacies
9.3.2. Independent E-Pharmacies
9.4. Retail Pharmacy
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
10. Cisatracurium Besilate Injection Market, by Form
10.1. Introduction
10.2. Powder For Reconstitution
10.3. Premixed Solution
11. Cisatracurium Besilate Injection Market, by Strength
11.1. Introduction
11.2. 2 Mg/Ml
11.3. 5 Mg/Ml
12. Cisatracurium Besilate Injection Market, by Route
12.1. Introduction
12.2. Intramuscular Injection
12.3. Intravenous Bolus
12.4. Intravenous Infusion
13. Cisatracurium Besilate Injection Market, by Application
13.1. Introduction
13.2. Cardiovascular Surgery
13.2.1. Coronary Artery Bypass
13.2.2. Heart Valve Surgery
13.3. General Surgery
13.3.1. Laparoscopic Surgery
13.3.2. Open Surgery
13.4. Neurological Surgery
13.4.1. Craniotomy
13.4.2. Spinal Surgery
13.5. Obstetrics & Gynecology
13.5.1. Cesarean Section
13.5.2. Hysterectomy
13.6. Orthopedic Surgery
13.6.1. Arthroscopy
13.6.2. Joint Replacement
14. Americas Cisatracurium Besilate Injection Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cisatracurium Besilate Injection Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cisatracurium Besilate Injection Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Fresenius Kabi AG
17.3.3. Sandoz International GmbH
17.3.4. Teva Pharmaceutical Industries Limited
17.3.5. Hikma Pharmaceuticals PLC
17.3.6. Viatris Inc.
17.3.7. Baxter International Inc.
17.3.8. Sun Pharmaceutical Industries Limited
17.3.9. Zhejiang Hisun Pharmaceutical Co., Ltd.
17.3.10. Jiangsu Hengrui Medicine Co., Ltd.
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. CISATRACURIUM BESILATE INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CISATRACURIUM BESILATE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CISATRACURIUM BESILATE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CISATRACURIUM BESILATE INJECTION MARKET: RESEARCHAI
FIGURE 28. CISATRACURIUM BESILATE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 29. CISATRACURIUM BESILATE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 30. CISATRACURIUM BESILATE INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CISATRACURIUM BESILATE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CORPORATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CORPORATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY BRANDED E-PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY BRANDED E-PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INDEPENDENT E-PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INDEPENDENT E-PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY POWDER FOR RECONSTITUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY POWDER FOR RECONSTITUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PREMIXED SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY PREMIXED SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY 2 MG/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY 2 MG/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY 5 MG/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY 5 MG/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAMUSCULAR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HEART VALVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HEART VALVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CRANIOTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 198. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 199. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 212. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 213. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 216. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 217. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 220. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 221. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 222. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 223. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 224. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 225. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 226. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 227. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 228. CANADA CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 246. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 247. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 256. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 257. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 258. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 259. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 260. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 261. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 262. MEXICO CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY NEUROLOGICAL SURGERY, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL CISATRACURIUM BESILATE INJECTION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 294.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cisatracurium Besilate Injection Market report include:
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Baxter International Inc.
  • Sun Pharmaceutical Industries Limited
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.